Citi analyst Patrick Donnelly lowered the price target on 10X Genomics (NASDAQ: TXG) to $20.00 (from $23.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

10X Genomics (TXG) PT Lowered to $18 at Canaccord GenuityFebruary 13, 2025 6:32 AM Leerink Partners Downgrades 10X Genomics (TXG) to Market PerformFebruary 13, 2025 6:06 AM Form 10-K 10x Genomics, Inc. For: Dec 31February 13, 2025 6:03 AM 10x Genomics (TXG) Misses Q4 EPS by 9c, provides guidanceFebruary 12, 2025 4:14 PM Form 8-K 10x Genomics, Inc. For: Feb 12February 12, 2025 4:10 PM 10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025February 12, 2025 4:05 PM